Home

Látszik kedves Szentély teva pharmaceuticals news globes barátság sarkantyú mániás

Teva to build new headquarters in Tel Aviv - Globes
Teva to build new headquarters in Tel Aviv - Globes

Teva Pharmaceutical Industries ADR (TEVA-N) Quote - The Globe and Mail
Teva Pharmaceutical Industries ADR (TEVA-N) Quote - The Globe and Mail

R.I. will receive more than $100m in latest opioid settlement - The Boston  Globe
R.I. will receive more than $100m in latest opioid settlement - The Boston Globe

Teva Pharma Buys Smart Inhaler Company Gecko Health | RT
Teva Pharma Buys Smart Inhaler Company Gecko Health | RT

Just 10% of Teva's employees located in Israel - Globes
Just 10% of Teva's employees located in Israel - Globes

Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva completes $40b purchase of Allergan generics arm | The Times of Israel

Teva share price jumps 55% in past three weeks - Globes
Teva share price jumps 55% in past three weeks - Globes

Teva stocks fall after company said named in US price-fixing drug 'cartel'  probe | The Times of Israel
Teva stocks fall after company said named in US price-fixing drug 'cartel' probe | The Times of Israel

Teva targets sub-Saharan Africa - Globes
Teva targets sub-Saharan Africa - Globes

Teva lied to evade accountability for role in New York's opioid crisis,  state attorney-general says - The Globe and Mail
Teva lied to evade accountability for role in New York's opioid crisis, state attorney-general says - The Globe and Mail

Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Pharmaceuticals (@TevaUSA) / Twitter

Teva announces debt recycling measures - Globes
Teva announces debt recycling measures - Globes

Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA)  | Seeking Alpha
Teva Pharmaceutical CEO Schultz stepping down in November 2023 - WSJ (TEVA) | Seeking Alpha

Israel sues Teva for $100m Copaxone royalties - Globes
Israel sues Teva for $100m Copaxone royalties - Globes

Teva misses on Q3 profit and revenue - Globes
Teva misses on Q3 profit and revenue - Globes

Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva recalls US-made drugs following contamination fears - The Boston Globe

Analysts see upside in Teva share price - גלובס
Analysts see upside in Teva share price - גלובס

Teva: 48 US states agree opioid settlement - Globes
Teva: 48 US states agree opioid settlement - Globes

Teva expands sustainability notes issue to $5b - גלובס
Teva expands sustainability notes issue to $5b - גלובס

Takeda, Astellas, Eisai—Fierce Pharma Asia
Takeda, Astellas, Eisai—Fierce Pharma Asia

Teva rejected opportunity to acquire Perrigo - גלובס
Teva rejected opportunity to acquire Perrigo - גלובס

Fresh woes emerge as Teva plunges to new lows - Globes
Fresh woes emerge as Teva plunges to new lows - Globes

Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ

Teva agrees to tentative $4.25 billion national settlement over opioids -  The Boston Globe
Teva agrees to tentative $4.25 billion national settlement over opioids - The Boston Globe

With $40 million pay, Teva breaks from custom for turnaround - The Boston  Globe
With $40 million pay, Teva breaks from custom for turnaround - The Boston Globe

Teva boosted as FDA delays generic Copaxone - Globes
Teva boosted as FDA delays generic Copaxone - Globes